ロード中...
Management of acute stroke in patients taking novel oral anticoagulants
Each year, 1·0–2·0% of individuals with atrial fibrillation and 0·1–0·2% of those with venous thromboembolism who are receiving one of the novel oral anticoagulants (dabigatran, rivaroxaban, or apixaban) can be expected to experience an acute ischemic stroke. Additionally, 0·2–0·5% of individuals wi...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4149783/ https://ncbi.nlm.nih.gov/pubmed/24891030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijs.12295 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|